177 related articles for article (PubMed ID: 3496093)
1. Competition of a growth stimulating-/cholecystokinin (CCK) releasing-peptide (monitor peptide) with epidermal growth factor for binding to 3T3 fibroblasts.
Fukuoka S; Fushiki T; Kitagawa Y; Sugimoto E; Iwai K
Biochem Biophys Res Commun; 1987 Jun; 145(2):646-50. PubMed ID: 3496093
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and properties of cholecystokinin-releasing peptide (monitor peptide), a 61-residue trypsin inhibitor.
Lin YZ; Isaac DD; Tam JP
Int J Pept Protein Res; 1990 Nov; 36(5):433-9. PubMed ID: 2276871
[TBL] [Abstract][Full Text] [Related]
3. A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cells.
Yamanishi R; Kotera J; Fushiki T; Soneda T; Saitoh T; Oomori T; Satoh T; Sugimoto E
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):57-63. PubMed ID: 8471054
[TBL] [Abstract][Full Text] [Related]
4. Monitor peptide binding sites are expressed in the rat liver and small intestine.
McVey DC; Romac JM; Clay WC; Kost TA; Liddle RA; Vigna SR
Peptides; 1999; 20(4):457-64. PubMed ID: 10458515
[TBL] [Abstract][Full Text] [Related]
5. Purification and sequencing of a trypsin-sensitive cholecystokinin-releasing peptide from rat pancreatic juice. Its homology with pancreatic secretory trypsin inhibitor.
Iwai K; Fukuoka S; Fushiki T; Tsujikawa M; Hirose M; Tsunasawa S; Sakiyama F
J Biol Chem; 1987 Jul; 262(19):8956-9. PubMed ID: 3597401
[TBL] [Abstract][Full Text] [Related]
6. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.
Bowen-Pope DF; Dicorleto PE; Ross R
J Cell Biol; 1983 Mar; 96(3):679-83. PubMed ID: 6300138
[TBL] [Abstract][Full Text] [Related]
7. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine.
Herzig KH; Schön I; Tatemoto K; Ohe Y; Li Y; Fölsch UR; Owyang C
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7927-32. PubMed ID: 8755579
[TBL] [Abstract][Full Text] [Related]
8. Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding.
Zachary I; Sinnett-Smith JW; Rozengurt E
J Cell Biol; 1986 Jun; 102(6):2211-22. PubMed ID: 3011811
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of genes encoding rat pancreatic cholecystokinin (CCK)-releasing peptide (monitor peptide) and pancreatic secretory trypsin inhibitor (PSTI).
Tsuzuki S; Miura Y; Fushiki T; Oomori T; Satoh T; Natori Y; Sugimoto E
Biochim Biophys Acta; 1992 Sep; 1132(2):199-202. PubMed ID: 1390891
[TBL] [Abstract][Full Text] [Related]
10. Luminal feedback regulation, monitor peptide, CCK-releasing peptide, and CCK receptors.
Miyasaka K; Funakoshi A
Pancreas; 1998 Apr; 16(3):277-83. PubMed ID: 9548667
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.
Niinobu T; Ogawa M; Murata A; Nishijima J; Mori T
J Exp Med; 1990 Oct; 172(4):1133-42. PubMed ID: 2170560
[TBL] [Abstract][Full Text] [Related]
12. CCK-releasing activity of rat intestinal secretion: effect of atropine and comparison with monitor peptide.
Guan D; Ohta H; Tawil T; Liddle RA; Green GM
Pancreas; 1990 Nov; 5(6):677-84. PubMed ID: 2281081
[TBL] [Abstract][Full Text] [Related]
13. Effect of a high-protein diet on the gene expression of a trypsin-sensitive, cholecystokinin-releasing peptide (monitor peptide) in the pancreas.
Tsuzuki S; Fushiki T; Kondo A; Murayama H; Sugimoto E
Eur J Biochem; 1991 Jul; 199(1):245-52. PubMed ID: 2065678
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction.
Watanabe T; Shintani A; Nakata M; Shing Y; Folkman J; Igarashi K; Sasada R
J Biol Chem; 1994 Apr; 269(13):9966-73. PubMed ID: 8144591
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory effect of monitor peptide and human pancreatic secretory trypsin inhibitor on pancreatic secretion and cholecystokinin release in conscious rats.
Miyasaka K; Nakamura R; Funakoshi A; Kitani K
Pancreas; 1989; 4(2):139-44. PubMed ID: 2755938
[TBL] [Abstract][Full Text] [Related]
16. Isolation and bioactivity of putative cholecystokinin-releasing peptide from rat small intestinal mucosa.
Miyasaka K; Funakoshi A
Gastroenterol Jpn; 1992 Feb; 27(1):83-7. PubMed ID: 1555750
[TBL] [Abstract][Full Text] [Related]
17. Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: modulation by heparin, heparinase, or synthetic heparin-binding HB-EGF fragments.
Besner GE; Whelton D; Crissman-Combs MA; Steffen CL; Kim GY; Brigstock DR
Growth Factors; 1992; 7(4):289-96. PubMed ID: 1306684
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of human pancreatic secretory trypsin inhibitor to various cultured cells.
Niinobu T; Ogawa M; Shibata T; Murata A; Nishibe S; Mori T; Ogata N
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):245-8. PubMed ID: 3489966
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic calcium regulates epidermal growth factor endocytosis in rat pancreas and cultured fibroblasts.
Korc M; Matrisian LM; Magun BE
Proc Natl Acad Sci U S A; 1984 Jan; 81(2):461-5. PubMed ID: 6320188
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cholecystokinin secretion by intraluminal releasing factors.
Liddle RA
Am J Physiol; 1995 Sep; 269(3 Pt 1):G319-27. PubMed ID: 7573441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
